Browsing publications by Dr David Kavanagh

Newcastle AuthorsTitleYearFull text
Professor Neil Sheerin
Dr David Kavanagh
Professor Tim Goodship
Dr Sally Johnson
A national specialised service in England for atypical haemolytic uraemic syndrome – the first year’s experience2015
Dr Edwin Wong
Dr David Kavanagh
Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome2015
Dr David Kavanagh
Structural basis for sialic acid-mediated self-recognition by complement factor H2015
Catriona Barker
Dr David Kavanagh
Professor Tim Goodship
Dr Kevin Marchbank
Autoantibodies to CD59, CD55, CD46 and CD35 are not associated with aHUS2014
Rachael Watson
Dr Karim Bennaceur
Catriona Barker
Dr David Kavanagh
Professor Tim Goodship
et al.
Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)2014
Dr Edwin Wong
Dr Holly Anderson
Rachel Challis
Dr Lisa Turnbull
Daniel Ahlert
et al.
Characterization of a Factor H Mutation That Perturbs the Alternative Pathway of Complement in a Family with Membranoproliferative GN2014
Dr David Kavanagh
Professor Neil Sheerin
Management of hemolytic uremic syndrome2014
Dr David Kavanagh
Thrombotic Microangiopathy Associated with Interferon Beta2014
Dr Edwin Wong
Dr David Kavanagh
Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration2014
Rachel Challis
Dr Holly Anderson
Dr Edwin Wong
Dr Lisa Turnbull
Dr Kevin Marchbank
et al.
Atypical haemolytic uraemic syndrome associated with a novel hybrid CFH/CFHR3 gene2013
1234567